½ÃÀ庸°í¼­
»óǰÄÚµå
1541387

½Ã½ºÅ×ÀÎ ½ÃÀå º¸°í¼­ : »ý»ê °øÁ¤, ¿ëµµ, ÃÖÁ¾ »ç¿ë »ê¾÷, Áö¿ªº°(2024-2032³â)

Cysteine Market Report by Production Process, Application, End Use Industry, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 136 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½Ã½ºÅ×ÀÎ ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³â 4¾ï 650¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 5¾ï 9,940¸¸ ´Þ·¯¿¡ ´ÞÇØ 2024³âºÎÅÍ 2032³â±îÁö 4.3%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. Á¦¾à ¹× ÆÛ½º³ÎÄÉ¾î »ê¾÷ÀÇ È®Àå, F&B ºÎ¹®ÀÇ ÀÀ¿ë ºÐ¾ß Áõ°¡, °Ç°­º¸Á¶½Äǰ¿¡ ´ëÇÑ ¼ö¿ä ±ÞÁõ µîÀÌ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½Ã½ºÅ×ÀÎ ½ÃÀå ºÐ¼®:

ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀμ¼°è Á¦¾à »ê¾÷ÀÇ °ý¸ñÇÒ¸¸ÇÑ ¼ºÀåÀº ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®´ÙÁÖ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, À½·á ¹× ½Äǰ »ê¾÷¿¡¼­ÀÇ Á¦Ç° º¸±ÞÀº ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ : È­Àåǰ ¹× ÆÛ½º³ÎÄɾî Á¦Ç° Á¦Á¶¿¡ ´ëÇÑ Á¦Ç° »ç¿ë Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±¤¹üÀ§ÇÑ ¿¬±¸ °³¹ß(R&D) Ȱµ¿°ú ¼ÒºñÀÚÀÇ ÁöÃâ ´É·Â Áõ°¡°¡ ½Ã½ºÅ×ÀÎ ½ÃÀå ¼ö¿ä¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°æÀï »óȲ : ½ÃÀå ³» À¯¸í ±â¾÷À¸·Î´Â Ajinomoto Co. Inc., CJ CheilJedang Corp., Merck KGaA, Nippon Rika Co. Ltd, Shanghai Cosroma Biotech Co. Ltd, Shine Star (Hubei) Biological Engineering Co. Ltd., Wacker Chemie AG, Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.), Wuxi Bikang Bioengineering Co. Ltd. µîÀÌ ÀÖ½À´Ï´Ù.

Áö¸®Àû µ¿Çâ : ½Ã½ºÅ×ÀÎ ½ÃÀå ¿ªÇп¡ µû¸£¸é ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ½ÃÀå¿¡¼­ ¶Ñ·ÇÇÑ ¿ìÀ§¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ½Ã½ºÅ×ÀÎÀº ½Äǰ ¹× À½·á »ê¾÷¿¡¼­ dz¹Ì Áõ°­Á¦ ¹× ¹ÝÁ× °³·®Á¦·Î »ç¿ëµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡°ø ½Äǰ, ½ÄÀ½·á ¹× À½·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½Ã½ºÅ×ÀÎ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

°úÁ¦ ¹× ±âȸ : ´Ù¾çÇÑ »ê¾÷ ºÐ¾ßÀÇ ±ÔÁ¦ Àå¾Ö¹°, ¿øÀÚÀç ºñ¿ë º¯µ¿, ´Ù¸¥ ´ëüǰ°úÀÇ °æÀïÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÇ·áºñ Áõ°¡, °Ç°­º¸Á¶½Äǰ ¹× Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä·Î ÀÎÇÑ Á¦¾à »ê¾÷ÀÇ È®ÀåÀº ¿ø·á·Î¼­ÀÇ ½Ã½ºÅ×Àο¡ ´ëÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

½Ã½ºÅ×ÀÎ ½ÃÀå µ¿Çâ:

ÀǾàǰ Á¦Á¦¿¡¼­ÀÇ È°¿ëµµ Áõ°¡

Á¦¾à Á¦Á¦¿¡¼­ ½Ã½ºÅ×ÀÎÀÇ »ç¿ë È®´ë´Â ½Ã½ºÅ×ÀÎ ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ½Ã½ºÅ×ÀÎÀº »ýÈ­ÇÐÀû Ư¼º°ú Ä¡·á È¿°ú·Î ÀÎÇØ ÀǾàǰ Á¦Çü¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ½Ã½ºÅ×ÀÎÀº È¿´É, ¾ÈÁ¤¼º ¹× »ýü ÀÌ¿ë·üÀ» Çâ»ó½Ã۱â À§ÇØ ´Ù¾çÇÑ ÀǾàǰ Á¦Çü¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, HealthlineÀÇ ±â»ç¿¡ µû¸£¸é ÃæºÐÇÑ ½Ã½ºÅ×ÀÎÀ» ¼·ÃëÇÏ´Â °ÍÀº ü³»¿¡¼­ °¡Àå °­·ÂÇÑ Ç×»êÈ­Á¦ÀÎ ±Û·çŸƼ¿ÂÀ» º¸ÃæÇÏ´Â µî ¿©·¯ °¡Áö ÀÌÀ¯·Î À¯ÀÍÇÏ´Ù°í ÇÕ´Ï´Ù. ÀÌ ¾Æ¹Ì³ë»êÀº ¶ÇÇÑ È£Èí±â Áúȯ, »ý½Ä ´É·Â ¹× ³ú ±â´ÉÀÇ Ä¡À¯¿¡µµ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ½Ã½ºÅ×ÀÎÀº ½ÉÇ÷°üÁúȯ, È£Èí±â Áúȯ, ½Å°æ Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀ» Ç¥ÀûÀ¸·Î ÇÏ´Â Á¦Á¦¿¡µµ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¼¼Æ÷ ³» ±Û·çŸƼ¿Â ¼öÄ¡ »ý¼ºÀ» µ½°í °£ ±â´ÉÀ» Áö¿øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 12¿ù °í°´ ¸¸Á·À» Áß½ÃÇÏ´Â ÇÁ·Î¹ÙÀÌ¿Àƽ½º ºê·£µåÀÎ Jarrow Formulas´Â 500mgÀÇ N-¾Æ¼¼Æ¿-L-½Ã½ºÅ×ÀÎÀ» ÇÔÀ¯ÇÑ Ã¤½ÄÁÖÀÇÀÚ Ä¸½¶ N-A-C¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ Á¦Ç°Àº °­·ÂÇÑ Ç×»êÈ­ ¾Æ¹Ì³ë»êÀ¸·Î ü³»¿¡¼­ Áß¿äÇÑ Ç×»êÈ­ ¹°ÁúÀÎ ±Û·çŸƼ¿Â(°£ °Ç°­À» ÃËÁøÇϴ ü³»¿¡¼­ °¡Àå Áß¿äÇϰí dzºÎÇÑ Ç×»êÈ­ ¹× ÇØµ¶ ¹°Áú Áß Çϳª)ÀÇ Àü±¸Ã¼ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ½Ã½ºÅ×ÀÎ ½ÃÀå Á¡À¯À²¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½Ä¹°¼º ´ëü ½Äǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

½Ä¹°¼º ´ëüǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ƯÈ÷ ½ÄÀ½·á¿¡¼­ ½Ã½ºÅ×ÀÎÀÇ ¿ªÇÒ·Î ÀÎÇØ ½Ã½ºÅ×ÀÎ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ ÃëÇâÀÌ Ã¤½ÄÁÖÀÇÀÚ ¹× ºñ°Ç ½Ä´ÜÀ¸·Î À̵¿ÇÔ¿¡ µû¶ó ´Ù¾çÇÑ À½·á ¹× ½Äǰ Ä«Å×°í¸®¿¡¼­ ½Ä¹°¼º ´ëüǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½Ã½ºÅ×ÀÎÀº ±âÁ¸¿¡´Â ±êÅÐÀ̳ª Àθð¿Í °°Àº µ¿¹°¼º Á¦Ç°¿¡¼­ °ø±ÞµÇ¾úÀ¸³ª, ÇöÀç´Â ÀÌ·¯ÇÑ ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ »ý¸í°øÇÐ °øÁ¤À» ÅëÇØ »ý»êÇϰųª ½Ä¹°¼º ¿ø·á¿¡¼­ ÃßÃâÇÏ¿© °ø±ÞÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 1¿ù µ§¸¶Å©ÀÇ »ý¸í°øÇÐ ±â¾÷ ¹ÙÀÌ¿À½ÅƼ¾Æ(Biosyntia)¿Í ¹ÀÇî¿¡ º»»ç¸¦ µÐ ¹ÙÄ¿ ±×·ì(Wacker Group)Àº ¹ßÈ¿ ±â¹Ý ºñ¿Àƾ »ý»êÀ» À¯·´ Àü¿ªÀ¸·Î È®´ëÇÒ °èȹÀ» ¼¼¿ü½À´Ï´Ù. ÀÌ ºñ¿ÀƾÀº ¿µ¾ç º¸ÃæÁ¦·Î »ç¿ëÇÒ ¼ö ÀÖÀ¸¸ç, ½ÄÀ½·á, À¯¾Æ ¿µ¾ç, °Ç°­º¸Á¶½Äǰ¿¡ Àû¿ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Wacker BioSolutions´Â ¹ßÈ¿ ±â¹Ý L-½Ã½ºÅ×ÀÎ, »çÀÌŬ·Îµ¦½ºÆ®¸°, ½Ä¹°¼º ¿¡Åº¿Ã·Î ¸¸µç ½Ç¸®ÄÜ ½Ç¶õÆ® µî ¼ºÀå ºÐ¾ß¸¦ À§ÇÑ ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ½Ã½ºÅ×ÀÎ »ê¾÷ÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ½Ä¹°¼º ½Ä´ÜÀº ½ÉÀå °Ç°­, üÁß °ü¸® ¹× Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ÀáÀçÀûÀÎ ÀÌÁ¡À¸·Î ÀÎÇØ Á¾Á¾ °Ç°­ÇÑ ¼±ÅÃÀ¸·Î Àνĵǰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ±¹¸³ ÀÇÇÐ µµ¼­°üÀÌ ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é ½Ä¹°¼º ½Ä´ÜÀº ÇãÇ÷¼º ½ÉÀå ÁúȯÀÇ À§Çè»Ó¸¸ ¾Æ´Ï¶ó ¸ðµç ¿øÀο¡ ÀÇÇÑ »ç¸Á·üµµ °¨¼Ò½Ãų ¼ö ÀÖÀ¸¸ç, ÀÌ´Â IHD »ç¸Á·ü °¨¼Ò¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ç÷¾Ð, Æ÷µµ´ç, ÄÝ·¹½ºÅ×·Ñ Á¶ÀýÀ» °³¼±ÇÏ°í ¾à¹°ÀÇ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ½Ä¹°¼º ½Ã½ºÅ×ÀÎÀº ÀÌ·¯ÇÑ °Ç°­ ¹× À£ºù Æ®·»µå¿¡ ºÎÇÕÇÏ¿© °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀڵ鿡°Ô ¾îÇÊÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ½Ã½ºÅ×ÀÎ ½ÃÀåÀÇ ¼öÀÍÀ» ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

¼ºÀåÇÏ´Â ½Äǰ °¡°ø »ê¾÷

Á¦»§ »ê¾÷ÀÇ ¼ºÀåÀº ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿ä¼Ò Áß ÇϳªÀÔ´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ º£ÀÌÄ¿¸® Çùȸ¿¡ µû¸£¸é ¹Ì±¹ º£ÀÌÄ¿¸® »ê¾÷Àº 1,860¾ï ´Þ·¯ÀÇ Àüü °æÁ¦ È¿°ú°¡ ÀÖ½À´Ï´Ù. ½Ã½ºÅ×ÀÎÀº ÀϹÝÀûÀ¸·Î »§, ÆÐ½ºÆ®¸®, ÇÇÀÚ ¹ÝÁ×°ú °°Àº Á¦°ú·ù ¹ÝÁ×ÀÇ ¹ÝÁ× ÄÁµð¼Å³Ê·Î »ç¿ëµË´Ï´Ù. ±×°ÍÀº ¹ÝÁ×ÀÇ Åº·Â, Áú°¨ ¹× ºÎÇǸ¦ °³¼±ÇÏ¿© ´õ ³ªÀº Á¦Ç° ǰÁú°ú Àϰü¼ºÀ¸·Î À̾îÁý´Ï´Ù. ÀÌ ¿Ü¿¡µµ ½Äǰ °¡°ø »ê¾÷µµ Áß¿äÇÑ ¼ºÀåÀ» ¾ò°í ÀÖÀ¸¸ç, ÀÌ´Â ½Ã½ºÅ×Àο¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Àεµ ºê·£µå ÁÖ½Ä Àç´Ü(India Brand Equity Foundation)ÀÌ ¹ßÇ¥ÇÑ ±â»ç¿¡ µû¸£¸é ½Äǰ °¡°ø ºÎ¹®Àº 2015³âºÎÅÍ 2022³â±îÁö ¿¬Æò±Õ 7.3%ÀÇ ³î¶ó¿î ¼ºÀå·üÀ» ±â·ÏÇß½À´Ï´Ù. ¶ÇÇÑ 2023³â 11¿ù ½Äǰ°¡°ø»ê¾÷ºÎ´Â ´ºµ¨¸®¿¡¼­ '¿ùµå Ǫµå Àεð¾Æ(World Food India)' Çà»ç¸¦ °³ÃÖÇϱ⵵ Çß½À´Ï´Ù. À̿ʹ º°µµ·Î °¡°ø½Äǰ°ú °£Æí½Ä¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä Áõ°¡·Î ÀÎÇØ °ü´ÉÀû Ư¼ºÀ» À¯ÁöÇϸ鼭 °¡°ø È¿À²°ú Á¦Ç° À¯Åë±âÇÑÀ» Çâ»ó½ÃŰ´Â ½Ã½ºÅ×Àΰú °°Àº ¼ººÐÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ±¹¸³ ÀÇÇÐ µµ¼­°üÀÌ ¹ßÇ¥ÇÑ ¿¬±¸¿¡ µû¸£¸é ½Ã½ºÅ×ÀÎÀº ºÎÆÐ¸¦ Áö¿¬½ÃŰ°í ÆÐƼÀÇ À¯Åë±âÇÑÀ» ¿¬ÀåÇÒ ¼ö ÀÖ´Ù°í ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ½Ã½ºÅ×ÀÎ ½ÃÀå ¿¹Ãø¿¡ ´õ¿í ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ½Ã½ºÅ×ÀÎ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : »ý»ê °øÁ¤º°

  • õ¿¬
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÇÕ¼º
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • ÄÁµð¼Å³Ê
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Ç÷¹À̹ö ÀÎÇÚ¼­
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ȯ¿øÁ¦
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Àΰ£ Àν¶¸° »ý»ê
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ ÀÌ¿ë »ê¾÷º°

  • ½Äǰ ¹× ½ÄÀ̺¸ÃæÁ¦
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Á¦¾à
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • È­Àåǰ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • µ¿¹° »ç·á
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï »óȲ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Ajinomoto Co. Inc.
    • CJ CheilJedang Corp.
    • Merck KGaA
    • Nippon Rika Co. Ltd
    • Shanghai Cosroma Biotech Co. Ltd
    • Shine Star(Hubei) Biological Engineering Co. Ltd.
    • Wacker Chemie AG
    • Wuhan Grand Hoyo Co. Ltd.(Grand Pharma(China) Co. Ltd.)
    • Wuxi Bikang Bioengineering Co.Ltd.
ksm 24.09.23

The global cysteine market size reached US$ 406.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 599.4 Million by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032. The expanding pharmaceutical and personal care industries, increasing applications in the F&B sector, the surging demand for health supplements, etc., are primarily propelling the market growth.

Cysteine Market Analysis:

Major Market Drivers: Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, the widespread product adoption in the food and beverage industry is providing a thrust to the market growth.

Key Market Trends: The increasing product utilization in the manufacturing of cosmetics and personal care products is contributing to the market growth. Furthermore, extensive research and development (R&D) activities, along with the increasing expenditure capacities of the consumers, are anticipated to drive the cysteine market demand.

Competitive Landscape: Some of the prominent companies in the market include Ajinomoto Co. Inc., CJ CheilJedang Corp., Merck KGaA, Nippon Rika Co. Ltd, Shanghai Cosroma Biotech Co. Ltd, Shine Star (Hubei) Biological Engineering Co. Ltd., Wacker Chemie AG, Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.), and Wuxi Bikang Bioengineering Co. Ltd., among many others.

Geographical Trends: According to the cysteine market dynamics, Asia Pacific exhibits a clear dominance in the market. Cysteine is used as a flavor enhancer and dough conditioner in the food and beverage industry. The rising demand for processed foods, bakery products, and beverages in the Asia Pacific region is driving the growth of the cysteine market.

Challenges and Opportunities: Regulatory hurdles in various industries, fluctuations in raw material costs, and competition for other alternatives are hampering the market growth. However, the pharmaceutical industry's expansion, driven by increasing healthcare expenditures and the demand for dietary supplements and therapeutic drugs, offers opportunities for cysteine as a raw material.

Cysteine Market Trends:

Increasing Utilization in the Formulation of Pharmaceutical Drugs

The increasing utilization of cysteine in the formulation of pharmaceutical drugs is significantly driving the growth of the cysteine market. Cysteine plays a crucial role in the formulation of pharmaceutical drugs due to its biochemical properties and therapeutic benefits. It is used in various drug formulations to enhance efficacy, stability, and bioavailability. For instance, according to an article published by Healthline, consuming enough cysteine is beneficial for various reasons, including replenishing the body's most powerful antioxidant, glutathione. These amino acids are also beneficial for curing respiratory issues, fertility, and brain function. Moreover, cysteine is used in formulations targeting chronic diseases such as cardiovascular disorders, respiratory diseases, and neurological ailments. It can aid in the production of cellular glutathione levels and support liver function. For instance, in December 2022, Jarrow Formulas, a probiotic brand focused on customer satisfaction, launched N-A-C, a vegetarian capsule containing 500mg of N-Acetyl-L-Cysteine. The product offering is a potent antioxidant amino acid that also serves as a precursor in the body to the key antioxidant glutathione - one of the body's most significant and abundant antioxidant and detoxifying agents that promotes liver health. These factors are further contributing to the cysteine market share.

Rising Demand for Plant-Based Alternatives

The increasing demand for plant-based alternatives is significantly driving growth in the cysteine market, particularly due to the role of cysteine in food and beverage products. As consumer preferences shift towards vegetarian or vegan diets, there is a growing demand for plant-based alternatives in various food and beverage categories. Cysteine, traditionally sourced from animal by-products like feathers or human hair, is now being produced through biotechnological processes or extracted from plant-based sources to cater to this demand. For instance, in January 2022, Danish biotech company, Biosyntia, and Munich-based, Wacker Group, planned to expand the production of fermentation-based biotin across Europe. This biotin was available as a dietary supplement and has potential applications in food & drinks, infant nutrition, and nutraceuticals. Wacker Biosolutions focuses on developing solutions for growth sectors, with products including fermentation-based L-Cysteine and cyclodextrins, and silicone sealants from plant-based ethanol. This is further driving the cysteine industry's growth. Besides this, plant-based diets are often perceived as healthier choices due to their potential benefits for heart health, weight management, and sustainability. For instance, according to an article published by the National Library of Medicine, plant-based diets can reduce all-cause mortality as well as the risk of ischemic heart disease, which is associated with lower IHD mortality. It can also improve blood pressure, glucose, and cholesterol control, reducing the need for drugs. Cysteine derived from plant sources aligns with these health and wellness trends, appealing to health-conscious consumers. These factors are further bolstering the cysteine market revenue.

Growing Food Processing Industry

The growing baking industry is one of the significant factors driving the market growth. For instance, according to the American Bakers Association, the American bakery industry has USD 186 billion in overall economic impact. Cysteine is commonly used as a dough conditioner in baked goods such as bread, pastries, and pizza crusts. It improves dough elasticity, texture, and volume, leading to better product quality and consistency. Apart from this, the food processing industry is also gaining significant growth which is further propelling the demand for cysteine. According to an article published by the India Brand Equity Foundation, the food processing sector has received an impressive average annual growth rate of 7.3% from 2015 to 2022. Also, in November 2023, the Ministry of Food Processing Industries hosted the 'World Food India" event, in New Delhi. Apart from this, the increasing demand for processed and convenience foods globally is driving the need for ingredients like cysteine that improve processing efficiency and product shelf life while maintaining sensory attributes. For instance, according to research published by the National Library of Medicine, cysteine can delay spoilage and extend the shelf life of patties. These factors are further positively impacting the cysteine market forecast.

Global Cysteine Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cysteine market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on production process, application, and end use industry.

Breakup by Production Process:

Natural

Synthetic

Currently, synthetic holds the majority of the total market share

The report has provided a detailed breakup and analysis of the market based on the production process. This includes natural and synthetic. According to the report, synthetic holds the majority of the total market share.

According to the cysteine market outlook, advances in chemical synthesis, enzymatic processes, and biotechnological methods have significantly improved the efficiency and cost-effectiveness of synthetic cysteine production. Continuous innovation in production techniques enhances scalability and reduces production costs, making synthetic cysteine more competitive compared to traditional extraction methods. Moreover, the increasing demand for cysteine as a food additive, particularly in the bakery and processed food sectors, is a major driver for synthetic production. Synthetic cysteine offers manufacturers a consistent and reliable source of amino acid, ensuring product quality and compliance with regulatory standards. Apart from this, the rising health benefits of synthetic cysteine is also driving the market growth. For instance, according to an article published by Forbes, NAC, a synthetic form of cysteine, may be an effective treatment for certain respiratory conditions, such as chronic bronchitis or chronic obstructive pulmonary disease.

Breakup by Application:

Conditioner

Flavor Enhancer

Reducing Agent

Human Insulin Production

Others

Flavor enhancer currently exhibits a clear dominance in the market

The report has provided a detailed breakup and analysis of the market based on the application. This conditioner, flavor enhancer, reducing agent, human insulin production, and others. According to the report, flavor enhancer currently exhibits a clear dominance in the market.

According to the cysteine market overview, cysteine is valued for its ability to enhance umami flavors and improve overall taste perception in food products. This makes it particularly sought after in savory and baked goods where rich, savory notes are desired. Moreover, cysteine's versatility allows it to be used in a wide range of food applications, including bakery products (e.g., bread, pastries, pizza crusts), snacks, soups, sauces, and processed meats. Its effectiveness in improving flavor profiles across diverse product categories contributes to its consistent demand. For instance, according to a sensory analysis published by Springer Nature in December 2023, 0.25-0.75% range of cysteine increased the meaty, caramel, umami, mouthfulness and salty notes, and caused a decrease in bitter taste of the MRPs as confirmed by GC-MS.

Breakup by End Use Industry:

Food and Dietary Supplement

Pharmaceutical

Cosmetic

Animal Feed

Others

Currently, food and dietary supplement accounts for the largest market share

The report has provided a detailed breakup and analysis of the market based on the end use industry. This includes food and dietary supplements, pharmaceutical, cosmetic, animal feed, and others. According to the cysteine market report, food and dietary supplement accounts for the largest market share.

Cysteine is a precursor to glutathione, a powerful antioxidant that helps protect cells from oxidative stress and supports overall immune health. Consumers are increasingly seeking supplements that provide antioxidant support to combat the effects of free radicals and promote cellular health. Moreover, glutathione, synthesized from cysteine, plays a crucial role in detoxifying harmful substances in the liver and other tissues. Dietary supplements containing cysteine are sought after for their potential to support liver function and aid in detoxification processes. For instance, in May 2024, Plexus Worldwide, a health and wellness company, launched IronWoman, an iron supplement specifically formulated for the unique needs of women. The supplement was made by combining L Plantarum strain, with cysteine, and Vitamin C to create a combination that offers superior iron absorption.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Asia Pacific accounts for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific currently dominates the global market.

According to the cysteine market statistics, the Asia Pacific region has a rapidly growing food industry, fueled by urbanization, changing dietary habits, and increasing disposable incomes. Cysteine is widely used as a food additive, particularly in baked goods and savory products, to enhance flavor and texture. The rising demand for processed and convenience foods along with the growing fast-food industry further drives the market for cysteine in this region. For instance, the National Bureau of Statistics of China reports that in 2022, full-service restaurants brought in Yuan 502.94 billion (USD 70.98 billion) in income, while fast-food restaurants brought in Yuan 157.82 billion (USD 22.24 billion). This observed the expansion of China's food industry. Moreover, with a rising awareness of health and wellness among consumers, there is an increasing demand for dietary supplements containing cysteine. Asian consumers are widely adopting supplements for antioxidant support, respiratory health, and overall well-being, contributing to the growth of the cysteine supplement market.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

Ajinomoto Co. Inc.

CJ CheilJedang Corp.

Merck KGaA

Nippon Rika Co. Ltd

Shanghai Cosroma Biotech Co. Ltd

Shine Star (Hubei) Biological Engineering Co. Ltd.

Wacker Chemie AG

Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.)

Wuxi Bikang Bioengineering Co. Ltd.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Cysteine Market Recent Developments:

May 2024: Plexus Worldwide, a health and wellness company, launched IronWoman, an iron supplement specifically formulated for the unique needs of women. The supplement was made by combining L Plantarum strain, with cysteine, and Vitamin C to create a combination that offers superior iron absorption.

April 2024: Doctor's Best Inc., a nutritional supplement firm, introduced two new products: Glutathione + Milk Thistle with Setria and Boswellia + UC-II.Milk thistle extract contains silymarin, which boosts cysteine levels in the liver, one of the major amino acids involved in glutathione production.

November 2023: Vital Beautie, owned by K-beauty giant Amorepacific, launched a retinol-based dietary supplement. The formulation included L-cysteine.

Key Questions Answered in This Report

  • 1. How big is the global cysteine market?
  • 2. What is the expected growth rate of the global cysteine market during 2024-2032?
  • 3. What are the key factors driving the global cysteine market?
  • 4. What has been the impact of COVID-19 on the global cysteine market?
  • 5. What is the breakup of the global cysteine market based on the production process?
  • 6. What is the breakup of the global cysteine market based on the application?
  • 7. What is the breakup of the global cysteine market based on the end-use industry?
  • 8. What are the key regions in the global cysteine market?
  • 9. Who are the key players/companies in the global cysteine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cysteine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Production Process

  • 6.1 Natural
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Synthetic
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Conditioner
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Flavor Enhancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Reducing Agent
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Human Insulin Production
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use Industry

  • 8.1 Food and Dietary Supplement
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cosmetic
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Animal Feed
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ajinomoto Co. Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 CJ CheilJedang Corp.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Merck KGaA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Nippon Rika Co. Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Shanghai Cosroma Biotech Co. Ltd
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Shine Star (Hubei) Biological Engineering Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Wacker Chemie AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Wuxi Bikang Bioengineering Co.Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦